Pure Financial Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.07M | Buy |
2,749
+776
| +39% | +$302K | 0.02% | 198 |
|
|
2025
Q1 | $858K | Buy |
1,973
+95
| +5% | +$41.3K | 0.02% | 187 |
|
|
2024
Q4 | $693K | Sell |
1,878
-337
| -15% | -$124K | 0.02% | 185 |
|
|
2024
Q3 | $1.15M | Buy |
2,215
+12
| +0.5% | +$6.24K | 0.03% | 145 |
|
|
2024
Q2 | $1.19M | Sell |
2,203
-40
| -2% | -$21.7K | 0.03% | 138 |
|
|
2024
Q1 | $1.16M | Buy |
2,243
+22
| +1% | +$11.4K | 0.04% | 143 |
|
|
2023
Q4 | $1.05M | Sell |
2,221
-236
| -10% | -$111K | 0.04% | 143 |
|
|
2023
Q3 | $1.07M | Buy |
2,457
+25
| +1% | +$10.9K | 0.04% | 124 |
|
|
2023
Q2 | $1.08M | Buy |
2,432
+574
| +31% | +$255K | 0.05% | 127 |
|
|
2023
Q1 | $854K | Buy |
1,858
+102
| +6% | +$46.9K | 0.04% | 134 |
|
|
2022
Q4 | $901K | Buy |
1,756
+3
| +0.2% | +$1.54K | 0.05% | 125 |
|
|
2022
Q3 | $796K | Buy |
1,753
+754
| +75% | +$342K | 0.05% | 127 |
|
|
2022
Q2 | $482K | Buy |
999
+9
| +0.9% | +$4.34K | 0.03% | 158 |
|
|
2022
Q1 | $486K | Buy |
990
+1
| +0.1% | +$491 | 0.02% | 149 |
|
|
2021
Q4 | $459K | Hold |
989
| – | – | 0.02% | 138 |
|
|
2021
Q3 | $369K | Buy |
989
+9
| +0.9% | +$3.36K | 0.03% | 140 |
|
|
2021
Q2 | $374K | Hold |
980
| – | – | 0.03% | 137 |
|
|
2021
Q1 | $352K | Hold |
980
| – | – | 0.04% | 134 |
|
|
2020
Q4 | $315K | Buy |
+980
| New | +$315K | 0.04% | 143 |
|